Description

AOD-9604 is a modified fragment of human growth hormone corresponding to amino acids 177-191 of the hGH C-terminus, with an added tyrosine at the N-terminal end (16 amino acids in total). It was developed to study the fat-metabolism activity attributed to this region of hGH.

What is AOD-9604?

Unlike full-length growth hormone, AOD-9604 does not bind the GH receptor in a way that raises IGF-1, and it is not a growth hormone secretagogue. Research interest centres on its effects on lipolysis and lipogenesis in adipocytes, which were studied in rodent models of obesity.

Research Applications

Adipocyte lipolysis and lipogenesis
Obesity and energy-balance models
Comparisons with full-length hGH and hGH fragment 176-191
Cartilage and connective tissue models

Product Specifications

Available sizes: 5mg (also available as AOD-9604 10mg)
Form: lyophilized powder in a sealed vial
Purity: ≥99% (HPLC), manufactured in the USA
Certificate of Analysis available for each batch
Storage: store lyophilized product at -20°C, protected from light

Further reading: our AOD-9604 research guide covers mechanism and published studies in more detail.

For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. Sold to qualified researchers for in-vitro and laboratory research.